Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 47335-531

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 47335-531). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-tramadol-100mg (Spl Tramadol 100mg)

Label for Tramadol Hydrochloride Extended-release Tablets 100 mg, oral tablet form, supplied as 30 tablets per bottle. The label includes dosage instructions to swallow tablets whole, the NDC number 47335-531-83, and displays the Sun Pharmaceutical Industries, Inc. logo as the labeler.*

FDA Label Image

Spl-tramadol-200mg (Spl Tramadol 200mg)

Drug facts and label information panel for Tramadol Hydrochloride Extended-release Tablets 200 mg. The label includes dosage information, storage instructions, warnings, distributor and manufacturer details (Sun Pharmaceutical Industries), NDC number, barcode, and packaging quantity of 30 tablets. The text advises swallowing tablets whole without splitting or crushing.*

FDA Label Image

Spl-tramadol-300mg (Spl Tramadol 300mg)

Label for Tramadol Hydrochloride Extended-release Tablets 300 mg by Sun Pharmaceutical Industries, Inc. The label specifies the tablets are extended-release and should be taken whole once daily. The product comes in a bottle of 30 tablets, with storage and dispensing instructions. Manufactured by Sun Pharmaceutical Industries Ltd., India.*

FDA Label Image

Spl-tramadol-figure1 (Spl Tramadol Figure1)

A line graph comparing tramadol concentration (ng/mL) over 24 hours between Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily and Immediate-Release Tramadol Tablets 50 mg every 6 hours. The x-axis represents time in hours, and the y-axis represents tramadol concentration.*

FDA Label Image

Spl-tramadol-figure2 (Spl Tramadol Figure2)

A line graph comparing M1 metabolite concentration (ng/mL) over 24 hours between Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily and Immediate-Release Tramadol Tablets 50 mg every 6 hours. The graph shows concentration trends with time (hours) on the x-axis and M1 concentration on the y-axis, illustrating different absorption profiles for the two formulations.*

FDA Label Image

Spl-tramadol-figure3 (Spl Tramadol Figure3)

A line graph comparing the proportion of subjects over percent change from baseline between two treatments: Placebo (solid line) and Tramadol Contramid (dashed line). The x-axis represents percent change from baseline (0 to 100), and the y-axis represents proportion (0.0 to 0.8). The graph shows decreasing proportions as percent change increases.*

FDA Label Image

Spl-tramadol-structure (Spl Tramadol Structure)

Chemical structure of Tramadol Hydrochloride showing its molecular arrangement with formula C16H25NO2 · HCl as presented in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.